Women's use of hormone therapy before and after the Women's Health Initiative: A psychosocial model of stability and change

Mary A. Gerend, Leona S. Aiken, Mindy J. Erchull, Angela Lapin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective.: This longitudinal study examined factors underlying hormone therapy (HT) use before and after termination of the landmark Women's Health Initiative (WHI) estrogen plus progestin HT trial in July 2002, after which dramatic reductions in HT use occurred. Methods.: A community sample of 324 women (aged 40-86) from Arizona was interviewed four times between 1995 and 2003. A model of medical and psychological factors underlying intentions for long-term HT use expressed in 1995/1996 was developed and employed to predict subsequent use and discontinued use pre- and post-WHI. Results.: Philosophy of menopause and perceived susceptibility to breast cancer predicted perceived benefits of and barriers to long-term HT use, beyond age, oophorectomy, and physician recommendation. Age, benefits, and barriers predicted intentions for long-term HT use over and above current use. Intentions predicted use 3 years later, controlling for previous use. HT use in 1995/1996 predicted use until the WHI announcement, but not thereafter. Oophorectomy predicted continued HT use before WHI trial termination; perceived barriers, expressed 8 years earlier, predicted discontinued use after WHI trial termination. Conclusions.: Medical and psychological factors predicted sustained and discontinued HT use before and after the WHI announcement. The WHI findings apparently activated potential barriers to use expressed almost a decade earlier.

Original languageEnglish (US)
Pages (from-to)158-164
Number of pages7
JournalPreventive Medicine
Volume43
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Women's Health
Hormones
Therapeutics
Ovariectomy
Psychology
Progestins
Menopause
Longitudinal Studies
Estrogens
Breast Neoplasms
Physicians

Keywords

  • Health belief model
  • Long-term post-menopausal hormone replacement therapy (HT, HRT)
  • Longitudinal study
  • Women's Health Initiative (WHI)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Women's use of hormone therapy before and after the Women's Health Initiative : A psychosocial model of stability and change. / Gerend, Mary A.; Aiken, Leona S.; Erchull, Mindy J.; Lapin, Angela.

In: Preventive Medicine, Vol. 43, No. 3, 09.2006, p. 158-164.

Research output: Contribution to journalArticle

Gerend, Mary A. ; Aiken, Leona S. ; Erchull, Mindy J. ; Lapin, Angela. / Women's use of hormone therapy before and after the Women's Health Initiative : A psychosocial model of stability and change. In: Preventive Medicine. 2006 ; Vol. 43, No. 3. pp. 158-164.
@article{d13960ab11f94ac7afdb72c7cc066185,
title = "Women's use of hormone therapy before and after the Women's Health Initiative: A psychosocial model of stability and change",
abstract = "Objective.: This longitudinal study examined factors underlying hormone therapy (HT) use before and after termination of the landmark Women's Health Initiative (WHI) estrogen plus progestin HT trial in July 2002, after which dramatic reductions in HT use occurred. Methods.: A community sample of 324 women (aged 40-86) from Arizona was interviewed four times between 1995 and 2003. A model of medical and psychological factors underlying intentions for long-term HT use expressed in 1995/1996 was developed and employed to predict subsequent use and discontinued use pre- and post-WHI. Results.: Philosophy of menopause and perceived susceptibility to breast cancer predicted perceived benefits of and barriers to long-term HT use, beyond age, oophorectomy, and physician recommendation. Age, benefits, and barriers predicted intentions for long-term HT use over and above current use. Intentions predicted use 3 years later, controlling for previous use. HT use in 1995/1996 predicted use until the WHI announcement, but not thereafter. Oophorectomy predicted continued HT use before WHI trial termination; perceived barriers, expressed 8 years earlier, predicted discontinued use after WHI trial termination. Conclusions.: Medical and psychological factors predicted sustained and discontinued HT use before and after the WHI announcement. The WHI findings apparently activated potential barriers to use expressed almost a decade earlier.",
keywords = "Health belief model, Long-term post-menopausal hormone replacement therapy (HT, HRT), Longitudinal study, Women's Health Initiative (WHI)",
author = "Gerend, {Mary A.} and Aiken, {Leona S.} and Erchull, {Mindy J.} and Angela Lapin",
year = "2006",
month = "9",
doi = "10.1016/j.ypmed.2006.04.008",
language = "English (US)",
volume = "43",
pages = "158--164",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Women's use of hormone therapy before and after the Women's Health Initiative

T2 - A psychosocial model of stability and change

AU - Gerend, Mary A.

AU - Aiken, Leona S.

AU - Erchull, Mindy J.

AU - Lapin, Angela

PY - 2006/9

Y1 - 2006/9

N2 - Objective.: This longitudinal study examined factors underlying hormone therapy (HT) use before and after termination of the landmark Women's Health Initiative (WHI) estrogen plus progestin HT trial in July 2002, after which dramatic reductions in HT use occurred. Methods.: A community sample of 324 women (aged 40-86) from Arizona was interviewed four times between 1995 and 2003. A model of medical and psychological factors underlying intentions for long-term HT use expressed in 1995/1996 was developed and employed to predict subsequent use and discontinued use pre- and post-WHI. Results.: Philosophy of menopause and perceived susceptibility to breast cancer predicted perceived benefits of and barriers to long-term HT use, beyond age, oophorectomy, and physician recommendation. Age, benefits, and barriers predicted intentions for long-term HT use over and above current use. Intentions predicted use 3 years later, controlling for previous use. HT use in 1995/1996 predicted use until the WHI announcement, but not thereafter. Oophorectomy predicted continued HT use before WHI trial termination; perceived barriers, expressed 8 years earlier, predicted discontinued use after WHI trial termination. Conclusions.: Medical and psychological factors predicted sustained and discontinued HT use before and after the WHI announcement. The WHI findings apparently activated potential barriers to use expressed almost a decade earlier.

AB - Objective.: This longitudinal study examined factors underlying hormone therapy (HT) use before and after termination of the landmark Women's Health Initiative (WHI) estrogen plus progestin HT trial in July 2002, after which dramatic reductions in HT use occurred. Methods.: A community sample of 324 women (aged 40-86) from Arizona was interviewed four times between 1995 and 2003. A model of medical and psychological factors underlying intentions for long-term HT use expressed in 1995/1996 was developed and employed to predict subsequent use and discontinued use pre- and post-WHI. Results.: Philosophy of menopause and perceived susceptibility to breast cancer predicted perceived benefits of and barriers to long-term HT use, beyond age, oophorectomy, and physician recommendation. Age, benefits, and barriers predicted intentions for long-term HT use over and above current use. Intentions predicted use 3 years later, controlling for previous use. HT use in 1995/1996 predicted use until the WHI announcement, but not thereafter. Oophorectomy predicted continued HT use before WHI trial termination; perceived barriers, expressed 8 years earlier, predicted discontinued use after WHI trial termination. Conclusions.: Medical and psychological factors predicted sustained and discontinued HT use before and after the WHI announcement. The WHI findings apparently activated potential barriers to use expressed almost a decade earlier.

KW - Health belief model

KW - Long-term post-menopausal hormone replacement therapy (HT, HRT)

KW - Longitudinal study

KW - Women's Health Initiative (WHI)

UR - http://www.scopus.com/inward/record.url?scp=33748295846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748295846&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2006.04.008

DO - 10.1016/j.ypmed.2006.04.008

M3 - Article

C2 - 16750263

AN - SCOPUS:33748295846

VL - 43

SP - 158

EP - 164

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 3

ER -